查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1198773

玻璃體切除術設備市場-增長、趨勢、COVID-19 影響和預測 (2023-2028)

Vitrectomy Devices Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 146 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

在預測期內，玻璃體切除術市場的複合年增長率預計為 7.4%。

COVID-19 大流行最初對玻璃體切除術市場產生了重大影響。 為了應對這一流行病，世界各地的醫院減少了門診部的現場護理，並最大限度地利用一線資源進行流行病管理。 在 JAMA Ophthalmol 2021 上發表的一項針對 17 個中心的 526,536 家研究發現，從 2020 年 3 月中旬到至少 5 月，激光、冷凍療法、視網膜脫離修復和其他形式的玻璃體切除術的使用顯著減少。沒錯。 此外，由於漫長的等待時間和患者對前往醫療機構的恐懼，就患者數量和手術而言，眼科是受影響最嚴重的專業之一。 然而，美國眼科學會 (AAO) 指出，在 COVID-19 流行期間應繼續進行緊急視網膜玻璃體切除術。 因此，COVID-19 爆發對其前身的市場增長產生了負面影響。 然而，隨著全球玻璃體切除術病例數恢復正常，市場受到關注。

此外，糖尿病性視網膜病變和視網膜脫離患病率的增加以及玻璃體切除術的技術進步是推動所研究市場增長的主要因素。 根據國際防盲協會 (IAPB) 的數據，全球約有 9300 萬人患有糖尿病性視網膜病變。 大約三分之一的糖尿病患者也有一定程度的糖尿病視網膜病變，預計每 10 人中就有 1 人會發展為威脅視力的疾病。 預計這些因素將增加對玻璃體切除術器械的需求，並促進所研究市場的增長。

根據 IDF 的數據，到 2021 年，大約 5.37 億 20-79 歲的成年人將患有糖尿病。 此外，糖尿病患者總數預計到 2030 年將增加到 6.43 億，到 2045 年將增加到 7.83 億。 此外，隸屬於 IAPB 的視力喪失專家組估計，到 2020 年，全球將有 100 萬人因糖尿病視網膜病變而失明，超過 300 萬人將出現中度至重度視力障礙。 此外，增加對糖尿病視網膜病變的篩查和增加對糖尿病視網膜病變認識的活動也促進了市場的增長。 例如，2022 年 11 月，全印度眼科學會 (AIOS) 和印度玻璃體視網膜學會 (VRSI) 組織了一場步行馬拉松，以紀念世界糖尿病日並提高人們對糖尿病性視網膜病變的認識。 因此，糖尿病視網膜病變和視網膜脫離患病率的增加有望加速全球玻璃體切除術市場的發展，並有望繼續增長，從而在預測期內推動研究市場的增長。

因此，由於上述因素，預計所研究的市場在分析期內將增長。 然而，患者不適和與玻璃體切除術相關的風險可能會阻礙市場增長。

玻璃體切割市場趨勢

玻璃體切割系統部分預計在預測期內實現增長

玻璃體切除術是一個快速發展的領域，越來越複雜的顯微外科器械使先進的手術成為可能。 近年來，技術進步使鞏膜切開術變得更小，減少了手術創傷並提高了玻璃體切除術的效率。 因此，先進玻璃體切除術系統的優勢有望增加醫生對這些產品的需求，最終推動市場增長。

近年來，玻璃體切割系統的多項技術進步進一步推動了市場增長。 例如，切割率超過每分鐘 10,000 次 (CPM) 的高速玻璃體切除術系統最近受到歡迎。 高切割率導致視網膜牽引力下降。 此外，市場巨頭不斷推出的產品對該細分市場的增長產生了積極影響。 例如，2022 年 3 月，DORC International 推出了具有視網膜、白內障和聯合手術能力的集成系統“EVA NEXUS”。 該產品的推出有望顯著增強公司的產品組合。 此外，2022 年 7 月，Bosch Health Companies 啟動了升級，以提高其 Stellaris Elite 視力增強系統的效率。 此升級包括將最大真空設置從 600 增加到 660mmHg，以及用於套管針/插管系統的增強型可拆卸閥蓋。 因此，由於上述因素，預計玻璃體切除術系統部分在預測期內將出現顯著增長。

北美有望主導玻璃體切割市場

北美最有望主導市場。 此外，美國熟練眼科醫生的可用性和日益老齡化的人口也是促進北美市場增長的主要因素之一。

主要產品的發布和批准、市場參與者的高度集中以及製造商在美國的存在是推動該國玻璃體切除術市場增長的一些因素。 例如，2022 年 4 月，Carl Zeiss AG 獲得了 FDA 對 QUATERA 700 系統的批准。 蔡司 QUATERA 700 旨在提高外科醫生從診所到手術室的工作流程效率。 這些持續的產品發布和批准預計將推動該地區的市場增長。

因此，由於上述因素，北美地區的市場有望增長。

玻璃體切除術設備市場競爭對手分析

由於全球和區域運營的公司數量有限，玻璃體切除術市場正在經歷一些整合。 競爭格局包括一些擁有大量市場份額的國際參與者，如愛爾康、博士倫健康公司、BVI、DORC Holding B.V.、強生、Geuder AG、NIDEK CO.、Carl Zeiss Meditec AG、Hoya Surgical Optics 和 Topcon Corporation . 包括本地公司和公司的分析。

其他好處

  • Excel 格式的市場預測 (ME) 表
  • 三個月的分析師支持

內容

第一章介紹

  • 研究假設和市場定義
  • 調查範圍

第二章研究方法論

第 3 章執行摘要

第四章市場動態

  • 市場概覽
  • 市場驅動因素
    • 糖尿病性視網膜病變和視網膜脫離的患病率增加
    • 玻璃體切除術的技術進步
  • 市場製約因素
    • 玻璃體切除術相關的患者不適和風險
  • 波特的五力分析
    • 新進入者的威脅
    • 買方/消費者議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 競爭公司之間的敵對關係

第 5 章市場細分（基於價值的市場規模：百萬美元）

  • 按產品類型
    • 玻璃體切割系統
    • 照明設備
    • 注入裝置
    • 樂器
    • 其他產品類型（可視化設備、光凝設備、冷凍治療設備）
  • 通過申請
    • 糖尿病視網膜病變
    • 視網膜脫離
    • 黃斑裂孔
    • 玻璃體積血
    • 其他用途（玻璃體飛蚊症、黃斑水腫）
  • 最終用戶
    • 醫院
    • 眼科診所
    • 門診手術中心
  • 按地區
    • 北美
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 德國
      • 英國
      • 法國
      • 意大利
      • 西班牙
      • 其他歐洲地區
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳大利亞
      • 韓國
      • 其他亞太地區
    • 中東
      • 海灣合作委員會
      • 南非
      • 其他中東地區
    • 南美洲
      • 巴西
      • 阿根廷
      • 其他南美洲

第六章競爭格局

  • 公司簡介
    • Alcon
    • Bausch Health Companies Inc.
    • BVI
    • DORC Holding B.V.
    • Johnson & Johnson
    • Geuder AG
    • NIDEK CO.
    • Carl Zeiss Meditec AG
    • Hoya Surgical Optics
    • Topcon Corporation

第7章 市場機會今後動向

簡介目錄
Product Code: 92781

The Vitrectomy Devices Market is expected to register a CAGR of 7.4% over the forecast period.

The COVID-19 pandemic initially had a significant impact on the market for vitrectomy devices. As a safety response to the pandemic, hospitals worldwide reduced in-person checkups in outpatient departments to maximize the use of resources on the front to manage the pandemic. According to a cross-sectional study of 526,536 procedures across 17 institutions published in JAMA Ophthalmol 2021, there was a significant decrease in the use of lasers and cryotherapy, retinal detachment repairs, and other vitrectomies from mid-March 2020 to at least May 2020. Moreover, ophthalmology has been one of the most severely impacted specialties regarding patient numbers and surgeries, owing to a long waiting time and a fear among patients visiting medical facilities. However, the American Academy of Ophthalmology (AAO) indicated that urgent or emergent vitreoretinal surgical procedures should continue during the COVID-19 pandemic. Thus, the COVID-19 outbreak affected the market's growth adversely in its preliminary phase; however, the market gained traction due to the normalcy in the number of vitrectomy surgeries globally.

Further, the increasing prevalence of diabetic retinopathy and retinal detachment and technological advances in vitrectomy procedures are among the major factors driving the growth of the market studied. According to the International Agency for the Prevention of Blindness (IAPB), approximately 93 million people globally have diabetic retinopathy. In addition, about 1 in 3 people with diabetes have some degree of diabetic retinopathy, and 1 in 10 are anticipated to develop a vision-threatening form of the disease. Such factors will likely boost the demand for vitrectomy devices, thereby contributing to the growth of the market studied.

According to the IDF, in 2021, approximately 537 million adults (20-79 years of age) were living with diabetes. In addition, it is anticipated that the total number of people living with diabetes will rise to 643 million by 2030 and 783 million by 2045. Furthermore, the Vision Loss Expert Group, a part of the IAPB Organization, estimated that in 2020, 1 million people were blind globally due to diabetic retinopathy, and over 3 million had moderate-to-severe vision impairment. Moreover, increasing screening for diabetic retinopathy and an increasing number of campaigns raising awareness of diabetic retinopathy is also driving the market growth. For instance, in November 2022, the All India Ophthalmological Society (AIOS) and Vitreo-Retinal Society of India (VRSI) commemorated World Diabetes Day by organizing a walking marathon to raise awareness for diabetic retinopathy. Thus, the increasing prevalence of diabetic retinopathy and retinal detachment is poised to accelerate the vitrectomy devices market globally and is expected to increase in the future, thereby driving the growth of the studied market over the forecast period.

Therefore, owing to the factors mentioned above, it is anticipated that the market studied will witness growth over the analysis period. However, patient discomfort and risks associated with the vitrectomy procedure are likely to impede the market's growth.

Vitrectomy Devices Market Trends

Vitrectomy Systems Segment is Expected to Witness Growth Over the Forecast Period

Vitrectomy is a rapidly advancing field, with increasingly refined microsurgical instrumentation allowing for advanced techniques. In recent years, technological advances have further led to the miniaturization of the scleral incision to mitigate the trauma of the surgical procedure and increase the efficiency of the vitrectomy. Hence, owing to the advantages of advancing vitrectomy systems, the demand for these products is likely to increase among physicians, ultimately driving the market's growth.

In recent years, several technological advancements in vitrectomy systems are further driving the market growth. For instance, high-speed vitrectomy systems with a cut rate of above 10,000 cuts/minute (CPM) have recently become popular. The higher cut rates lead to a decrease in retinal traction. Furthermore, continuous product launches by major players in the market are positively affecting the segment's growth. For instance, in March 2022, DORC International launched EVA NEXUS, an integrated system with retina, cataract, and combined surgery capabilities. This product launch is anticipated to enhance its product portfolio significantly. Further, in July 2022, Bausch Health Companies, Inc. launched efficiency-enhancing upgrades for the Stellaris Elite vision enhancement system. The upgrades include increasing the maximum vacuum setting from 600 to 660 mmHg and enhancing the removable valve caps in the trocar/cannula system. Therefore, the vitrectomy systems segment is expected to witness significant growth over the forecast period due to the abovementioned factors.

North America is Expected to Dominate the Vitrectomy Devices Market

North America is expected to dominate the market owing to factors such as the easy availability of technologically advanced products, the growing prevalence of eye-related disorders, high awareness of diabetic retinopathy, and a significant uptake in medical screening in the region. In addition, the availability of skilled ophthalmologists and the increasing geriatric population in the United States are among the key factors contributing to the growth of the market studied in North America.

Key product launches and approvals, the high concentration of market players, and the manufacturer's presence in the United States are some of the factors driving the growth of the vitrectomy devices market in the country. For instance, in April 2022, Carl Zeiss AG received FDA approval for the QUATERA 700 system. The ZEISS QUATERA 700 is designed to increase a surgeon's workflow efficiency from the clinic to the operating room. These continuous product launches and approvals in the region are anticipated to drive market growth in the country.

Therefore, owing to the factors mentioned above, the growth of the studied market is anticipated in the North American region.

Vitrectomy Devices Market Competitor Analysis

The vitrectomy devices market is slightly consolidated due to the presence of limited companies operating globally and regionally. The competitive landscape includes an analysis of a few international as well as local companies that hold significant market shares, including Alcon, Bausch Health Companies Inc., BVI, DORC Holding B.V., Johnson & Johnson, Geuder AG, NIDEK CO., Carl Zeiss Meditec AG, Hoya Surgical Optics, and Topcon Corporation, among others.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Prevalence of Diabetic Retinopathy and Retinal Detachment
    • 4.2.2 Technological Advances in Vitrectomy Procedures
  • 4.3 Market Restraints
    • 4.3.1 Patient Discomfort and Risks Associated with the Vitrectomy Procedure
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Product Type
    • 5.1.1 Vitrectomy System
    • 5.1.2 Illumination Devices
    • 5.1.3 Infusion Devices
    • 5.1.4 Instruments
    • 5.1.5 Other Product Types (Visualization Devices, Photocoagulation Devices, Cryotherapy Devices)
  • 5.2 By Application
    • 5.2.1 Diabetic Retinopathy
    • 5.2.2 Retinal Detachment
    • 5.2.3 Macular Hole
    • 5.2.4 Vitreous Hemorrhage
    • 5.2.5 Other Applications (Vitreous floaters, Macular Pucker)
  • 5.3 By End-Users
    • 5.3.1 Hospitals
    • 5.3.2 Ophthalmology Clinics
    • 5.3.3 Ambulatory Surgical Centers
  • 5.4 By Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle-East
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle East
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Alcon
    • 6.1.2 Bausch Health Companies Inc.
    • 6.1.3 BVI
    • 6.1.4 DORC Holding B.V.
    • 6.1.5 Johnson & Johnson
    • 6.1.6 Geuder AG
    • 6.1.7 NIDEK CO.
    • 6.1.8 Carl Zeiss Meditec AG
    • 6.1.9 Hoya Surgical Optics
    • 6.1.10 Topcon Corporation

7 MARKET OPPORTUNITIES AND FUTURE TRENDS